We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$31.1B
AUM Growth
+$1.68B
Cap. Flow
+$21M
Cap. Flow %
0.07%
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$39M
2
HPE icon
Hewlett Packard
HPE
+$35.3M
3
SYF icon
Synchrony
SYF
+$29.5M
4
CMCSA icon
Comcast
CMCSA
+$25.4M
5
ILMN icon
Illumina
ILMN
+$13.5M

Sector Composition

Rank Sector Weight
1 Financials 15.31%
2 Healthcare 14.62%
3 Technology 14.1%
4 Industrials 10.66%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMO
2076
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$657K ﹤0.01%
71,983
+7,975
+12% +$61.5K
SCAI
2077
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$655K ﹤0.01%
16,460
+1,590
+11% +$55.3K
UIS icon
2078
Unisys
UIS
$213M
$654K ﹤0.01%
59,169
-1,815
-3% -$23K
ANAT
2079
DELISTED
American National Group, Inc. Common Stock
ANAT
$654K ﹤0.01%
6,392
+785
+14% +$81.1K
TVTY
2080
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$650K ﹤0.01%
50,490
+1,825
+4% +$22.2K
EPIQ
2081
DELISTED
EPIQ SYSTEMS INC
EPIQ
$649K ﹤0.01%
49,670
+2,450
+5% +$33K
FORM icon
2082
FormFactor
FORM
$9.09B
$647K ﹤0.01%
71,879
+3,345
+5% +$27.8K
AMRI
2083
DELISTED
Albany Molecular Research Inc
AMRI
$647K ﹤0.01%
32,576
+825
+3% +$15.7K
ALJ
2084
DELISTED
Alon USA Energy Inc
ALJ
$647K ﹤0.01%
43,618
-625
-1% -$10.5K
MSEX icon
2085
Middlesex Water
MSEX
$1.08B
$644K ﹤0.01%
24,252
+870
+4% +$22.2K
CWEN.A
2086
DELISTED
Clearway Energy Class A
CWEN.A
$641K ﹤0.01%
46,103
+2,640
+6% +$35.9K
UFI icon
2087
UNIFI
UFI
$128M
$640K ﹤0.01%
22,751
+1,050
+5% +$31K
OME
2088
DELISTED
Omega Protein
OME
$638K ﹤0.01%
28,737
+475
+2% +$9.89K
HSTM icon
2089
HealthStream
HSTM
$813M
$637K ﹤0.01%
28,960
+2,185
+8% +$51K
TRU icon
2090
TransUnion
TRU
$15.1B
$637K ﹤0.01%
+23,091
New +$594K
AVTA
2091
DELISTED
Avantax, Inc. Common Stock
AVTA
$637K ﹤0.01%
64,957
-1,960
-3% -$21.6K
CCG
2092
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
$635K ﹤0.01%
93,452
+3,170
+4% +$20.5K
TTMI icon
2093
TTM Technologies
TTMI
$14.6B
$634K ﹤0.01%
97,350
+4,910
+5% +$35.2K
BT
2094
DELISTED
BT Group plc (ADR)
BT
$634K ﹤0.01%
18,320
+600
+3% +$21.1K
VWR
2095
DELISTED
VWR Corporation
VWR
$633K ﹤0.01%
22,361
+2,255
+11% +$59.8K
DHX icon
2096
DHI Group
DHX
$173M
$632K ﹤0.01%
68,899
+4,220
+7% +$37.6K
SPPI
2097
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$632K ﹤0.01%
104,755
+6,400
+7% +$36.6K
RDS.B
2098
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$632K ﹤0.01%
13,722
+900
+7% +$45.5K
CTRE icon
2099
CareTrust REIT
CTRE
$9.7B
$631K ﹤0.01%
57,626
+8,905
+18% +$98.4K
GABC icon
2100
German American Bancorp
GABC
$1.91B
$631K ﹤0.01%
28,428
-2,453
-8% -$52.9K

Similar funds

RhumbLine Advisers's Q4 2015 Portfolio in Review

As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

  • RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
  • RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
  • RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
  • RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
  • RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
  • RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.

Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.